Comparison of clinical characteristics between patients with coronavirus disease 2019 (COVID-19) who retested RT-PCR positive versus negative: a retrospective study of data from Nanjing

The epidemiological and clinical characteristics of patients with coronavirus disease 2019 (COVID-19) have been reported. However, the prevalence of retesting positive by RT-PCR for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and the associated patient characteristics, remain u...

Full description

Saved in:
Bibliographic Details
Published inJournal of thoracic disease Vol. 12; no. 11; pp. 6435 - 6445
Main Authors Liu, Yuan, Ding, Ning, Zhou, Shixiang, Chen, Chen, Huang, Shan, Lv, Yanling, Jiao, Damin, Zheng, Yishan, Hu, Zhiliang, Xu, Chuanjun, Chen, Wei, Dai, Hui, Sun, Wenkui, Cheng, Cong, Lv, Ru, Cheng, Jian, Ye, Zi, Li, Zhengjie, Yi, Yongxiang, Wei, Hongxia
Format Journal Article
LanguageEnglish
Published China AME Publishing Company 01.11.2020
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The epidemiological and clinical characteristics of patients with coronavirus disease 2019 (COVID-19) have been reported. However, the prevalence of retesting positive by RT-PCR for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and the associated patient characteristics, remain unclear. We included 90 confirmed cases of COVID-19 treated in the Nanjing Public Health Center from January 20, 2020 to February 16, 2020 in this retrospective study. All patients completed treatment for COVID-19 and were retested by RT-PCR for SARS-CoV-2 4-20 days after completion of therapy. The clinical characteristics between patients with who retested positive versus negative by RT-PCR were compared, and the factors predictive of positive retesting were analyzed. Positive retesting was modeled with the area under the receiver operating characteristic curve (AUC). The age range of the study population was 0.8-97 years, and all patients were cured or showed improvement. A total of 10 (11%) patients retested positive by RT-PCR 4-20 days after completion of therapy. As compared with patients who retested negative, those who retested positive had a lower percentage of pre-admission fever, a higher percentage of post-admission fever, a lower percentage of bilateral lung infection, higher white blood cell (WBC) count and creatine phosphokinase, and lower hypersensitive c-reactive protein (hs-CRP), interleukin-6 and erythrocyte sedimentation rates (all P<0.05). Logistic regression analysis of the above eight key variables showed that lower hs-CRP and higher WBC were independently associated with positive retesting by RT-PCR. A combination of hs-CRP and WBC were predictive of positive retesting, with an AUC of 0.859. Patients with COVID-19 who retested positive by RT-PCR for SARS-CoV-2 had mild symptoms and better blood testing results. A combination of hs-CRP and WBC may predict positive retesting by RT-PCR; however, the sensitivity and specificity should be studied further.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
These authors contributed equally to this work.
Contributions: (I) Conception and design: Y Liu, N Ding, Y Yi, H Wei; (II) Administrative support: Y Yi, H Wei; (III) Provision of study materials or patients: None; (IV) Collection and assembly of data: Y Liu, S Zhou, C Chen, S Huang, Y Lv, D Jiao, Y Zheng, Z Hu, C Xu, W Chen, H Dai, W Sun, C Cheng, R Lv, J Cheng, Z Ye, Z Li; (V) Data analysis and interpretation: N Ding, H Dai; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors.
ISSN:2072-1439
2077-6624
DOI:10.21037/jtd.2020.04.17